SEC Filing Summary: AspenBio Pharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on April 29, 2009, reporting events occurring on April 28, 2009. The registrant is incorporated in Colorado and operates from Castle Rock, CO. Note: The request metadata referenced "Riot Platforms, Inc."; however, the provided filing text explicitly identifies the registrant as AspenBio Pharma, Inc.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document solely references the incorporation of a PowerPoint presentation.
Guidance, Outlook, and Management Commentary
Under Item 7.01 (Regulation FD Disclosure), the company incorporated by reference a PowerPoint presentation dated April 2009 (Exhibit 99.1). The filing states this information is available on the Company's website. No specific guidance, risks, or management commentary is included in the text of the 8-K itself.
Key Facts for Investor Verification
- Verify the content of the "Power Point Presentation" (Exhibit 99.1) referenced in the filing, as the substantive disclosure is contained therein.
- Confirm the registrant identity is AspenBio Pharma, Inc., not Riot Platforms, Inc., based on the charter name in the filing.
- Check the company's official website for the presentation dated April 2009 to obtain the actual business updates or financial data.